These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9292008)

  • 1. A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.
    Wang Z; Christensen N; Schiller JT; Dillner J
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2209-15. PubMed ID: 9292008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
    Wang X; Wang Z; Christensen ND; Dillner J
    Virology; 2003 Jun; 311(1):213-21. PubMed ID: 12832218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological analyses of human papillomavirus capsids.
    Giroglou T; Sapp M; Lane C; Fligge C; Christensen ND; Streeck RE; Rose RC
    Vaccine; 2001 Feb; 19(13-14):1783-93. PubMed ID: 11166904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
    Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
    J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
    J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to human papillomavirus 16, 18, 58, and 6b major capsid proteins among Japanese females.
    Matsumoto K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Jpn J Cancer Res; 1997 Apr; 88(4):369-75. PubMed ID: 9197528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.
    Wang Z; Hansson BG; Forslund O; Dillner L; Sapp M; Schiller JT; Bjerre B; Dillner J
    J Clin Microbiol; 1996 Dec; 34(12):3056-62. PubMed ID: 8940448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia.
    Matsumoto K; Yasugi T; Oki A; Fujii T; Nagata C; Sekiya S; Hoshiai H; Taketani Y; Kanda T; Kawana T; Yoshikawa H
    Cancer Lett; 2006 Jan; 231(2):309-13. PubMed ID: 16399232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma.
    Heino P; Eklund C; Fredriksson-Shanazarian V; Goldman S; Schiller JT; Dillner J
    J Natl Cancer Inst; 1995 Mar; 87(6):437-40. PubMed ID: 7532227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.
    Sasagawa T; Rose RC; Azar KK; Sakai A; Inoue M
    Int J Cancer; 2003 Apr; 104(3):328-35. PubMed ID: 12569556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein.
    Sapp M; Kraus U; Volpers C; Snijders PJ; Walboomers JM; Streeck RE
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3375-83. PubMed ID: 7996132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
    Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P
    J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of the antibody against human papillomavirus type 16 virion protein L2 in patients with cervical cancer and dysplasia.
    Kanda T; Teshima H; Katase K; Umezawa S; Watabe H; Takahashi H; Onda T; Yoshiike K
    Intervirology; 1995; 38(3-4):187-91. PubMed ID: 8682615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
    Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
    Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions.
    Sasagawa T; Yamazaki H; Dong YZ; Satake S; Tateno M; Inoue M
    Int J Cancer; 1998 Feb; 75(4):529-35. PubMed ID: 9466652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
    Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
    Int J Cancer; 1990 Mar; 45(3):529-35. PubMed ID: 1689705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.